CVE-2023-41088
CVE-2023-41088 is a medium-severity vulnerability in Dexma Dexgate with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-319.
Key facts
- Severity: Medium (CVSS 3.x base score 6.3)
- EPSS exploit prediction: 0% (15th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-319
- Affected product: Dexma Dexgate
- Published:
- Last modified:
Description
The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
Frequently asked questions
- What is CVE-2023-41088?
- The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.
- How severe is CVE-2023-41088?
- CVE-2023-41088 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity low, and availability none.
- Is CVE-2023-41088 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (15th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-41088?
- CVE-2023-41088 affects Dexma Dexgate. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-41088?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-41088 published?
- CVE-2023-41088 was published on 2023-10-19 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*
More vulnerabilities in Dexma Dexgate
- CVE-2023-41089 — High (CVSS 8.0): The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to…
- CVE-2023-42435 — Medium (CVSS 5.5): The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to…
- CVE-2023-40153 — Medium (CVSS 5.4): The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the…
- CVE-2023-42666 — Medium (CVSS 5.3): The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability,…
All CVEs affecting Dexma Dexgate →
Other CWE-319 (Cleartext Transmission of Sensitive Information) vulnerabilities
- CVE-2025-4378 — Critical (CVSS 10.0): Cleartext Transmission of Sensitive Information, Use of Hard-coded Credentials vulnerability in Ataturk University…
- CVE-2025-47419 — Critical (CVSS 10.0): Cleartext Transmission of Sensitive Information vulnerability in Crestron Automate VX allows Sniffing Network…
- CVE-2026-48902 — Critical (CVSS 9.8): The password and username reset features created plain http links for https connections if the "Force SSL" flag wasn't…
- CVE-2025-34271 — Critical (CVSS 9.8): Nagios Log Server versions prior to 2024R2.0.2 contain a vulnerability in the cluster manager component when…
- CVE-2025-32880 — Critical (CVSS 9.8): An issue was discovered on COROS PACE 3 devices through 3.0808.0. It implements a function to connect the watch to a…
- CVE-2025-26199 — Critical (CVSS 9.8): CloudClassroom-PHP-Project v1.0 is affected by an insecure credential transmission vulnerability. The application…
Browse all CWE-319 (Cleartext Transmission of Sensitive Information) vulnerabilities →